يعرض 881 - 900 نتائج من 2,072 نتيجة بحث عن '(( significant decrease decrease ) OR ( significant progress decrease ))~', وقت الاستعلام: 0.35s تنقيح النتائج
  1. 881

    Forest plot for FEV1. حسب Xuqin Du (8803772)

    منشور في 2025
    "…Compared to standard treatment, QJHTD significantly improved pulmonary function, with increases in FEV1 (MD = 0.32, 95% CI [0.25, 0.38], <i>p </i>= 0.000), FVC (MD = 0.30, 95% CI [0.22, 0.37], <i>p </i>= 0.000), FEV1/FVC (MD = 5.58, 95% CI [4.81, 6.34], <i>p </i>= 0.000), and PaO<sub>2</sub> (MD = 9.62, 95% CI [6.17, 13.08], <i>p </i>= 0.000), and a decrease in PaCO<sub>2</sub> (MD = -9.12, 95% CI [–11.96, –6.28], <i>p </i>= 0.000). …"
  2. 882

    The excluded and included studies were listed. حسب Xuqin Du (8803772)

    منشور في 2025
    "…Compared to standard treatment, QJHTD significantly improved pulmonary function, with increases in FEV1 (MD = 0.32, 95% CI [0.25, 0.38], <i>p </i>= 0.000), FVC (MD = 0.30, 95% CI [0.22, 0.37], <i>p </i>= 0.000), FEV1/FVC (MD = 5.58, 95% CI [4.81, 6.34], <i>p </i>= 0.000), and PaO<sub>2</sub> (MD = 9.62, 95% CI [6.17, 13.08], <i>p </i>= 0.000), and a decrease in PaCO<sub>2</sub> (MD = -9.12, 95% CI [–11.96, –6.28], <i>p </i>= 0.000). …"
  3. 883

    Forest plot for PaCO<sub>2</sub>. حسب Xuqin Du (8803772)

    منشور في 2025
    "…Compared to standard treatment, QJHTD significantly improved pulmonary function, with increases in FEV1 (MD = 0.32, 95% CI [0.25, 0.38], <i>p </i>= 0.000), FVC (MD = 0.30, 95% CI [0.22, 0.37], <i>p </i>= 0.000), FEV1/FVC (MD = 5.58, 95% CI [4.81, 6.34], <i>p </i>= 0.000), and PaO<sub>2</sub> (MD = 9.62, 95% CI [6.17, 13.08], <i>p </i>= 0.000), and a decrease in PaCO<sub>2</sub> (MD = -9.12, 95% CI [–11.96, –6.28], <i>p </i>= 0.000). …"
  4. 884

    Forest plot for PaO<sub>2</sub>. حسب Xuqin Du (8803772)

    منشور في 2025
    "…Compared to standard treatment, QJHTD significantly improved pulmonary function, with increases in FEV1 (MD = 0.32, 95% CI [0.25, 0.38], <i>p </i>= 0.000), FVC (MD = 0.30, 95% CI [0.22, 0.37], <i>p </i>= 0.000), FEV1/FVC (MD = 5.58, 95% CI [4.81, 6.34], <i>p </i>= 0.000), and PaO<sub>2</sub> (MD = 9.62, 95% CI [6.17, 13.08], <i>p </i>= 0.000), and a decrease in PaCO<sub>2</sub> (MD = -9.12, 95% CI [–11.96, –6.28], <i>p </i>= 0.000). …"
  5. 885
  6. 886

    Supplementary materials. حسب Yongki Welliam (21030005)

    منشور في 2025
    "…Subgroup analysis showed that increased KIM-1 in urine or blood was strongly associated with ESRD, and decreased Fetuin-A levels in Asians had a significant association with the incidence of ESRD.…"
  7. 887

    Summary of subgroup analysis results. حسب Yongki Welliam (21030005)

    منشور في 2025
    "…Subgroup analysis showed that increased KIM-1 in urine or blood was strongly associated with ESRD, and decreased Fetuin-A levels in Asians had a significant association with the incidence of ESRD.…"
  8. 888

    PRISMA Flow Chart 2020. حسب Yongki Welliam (21030005)

    منشور في 2025
    "…Subgroup analysis showed that increased KIM-1 in urine or blood was strongly associated with ESRD, and decreased Fetuin-A levels in Asians had a significant association with the incidence of ESRD.…"
  9. 889

    Included and excluded studies. حسب Yongki Welliam (21030005)

    منشور في 2025
    "…Subgroup analysis showed that increased KIM-1 in urine or blood was strongly associated with ESRD, and decreased Fetuin-A levels in Asians had a significant association with the incidence of ESRD.…"
  10. 890

    Characteristics of included studies. حسب Yongki Welliam (21030005)

    منشور في 2025
    "…Subgroup analysis showed that increased KIM-1 in urine or blood was strongly associated with ESRD, and decreased Fetuin-A levels in Asians had a significant association with the incidence of ESRD.…"
  11. 891

    Extraction data table. حسب Yongki Welliam (21030005)

    منشور في 2025
    "…Subgroup analysis showed that increased KIM-1 in urine or blood was strongly associated with ESRD, and decreased Fetuin-A levels in Asians had a significant association with the incidence of ESRD.…"
  12. 892

    S1 Raw images - حسب Yoon Seok Nam (20678482)

    منشور في 2025
    "…AS also involves the cochlea, causing late-onset progressive hearing loss. Currently, there are no therapeutic drugs to protect hearing from AS. …"
  13. 893
  14. 894
  15. 895

    Original images for explaining Fig 4. حسب Reiri Takeuchi (20460788)

    منشور في 2024
    "…Treatment with cyclosporine A also increased <i>MYC</i> and <i>ATM</i> mRNA expression levels and decreased <i>CDK2</i>, <i>ATR</i>, <i>P27</i>, <i>P53</i> and <i>RB1</i> mRNA expression levels but not significantly. …"
  16. 896

    Plants components in five-flower remedy [24]. حسب Walaiporn Plirat (17775628)

    منشور في 2025
    "…Parasitemia levels, clinical progression, behavioral changes, and histopathological analysis of brain tissue were analyzed. …"
  17. 897
  18. 898

    Raw data for ASV analysis. حسب Fittree Hayeeawaema (20775941)

    منشور في 2025
    "…<div><p>Probiotics are well-known therapeutic agents for managing constipation and have been used to improve chronic kidney disease (CKD) progression. However, heat-killed probiotics on CKD remain inadequately explored. …"
  19. 899

    Raw data. حسب Fittree Hayeeawaema (20775941)

    منشور في 2025
    "…<div><p>Probiotics are well-known therapeutic agents for managing constipation and have been used to improve chronic kidney disease (CKD) progression. However, heat-killed probiotics on CKD remain inadequately explored. …"
  20. 900